Daily Program
- Current Page
- Scientific Program > Daily Program
November 16 (Fri), 2018
| Nov 16 (Fri), 2018 | ||
|---|---|---|
| Room A | ||
| At the Start Line of Official Journal of the Korean Society of Heart Failure | ||
| 08:45-09:45 | 디지털 시대 학술지 창간 전략 | 최동주, 이은소 |
| 08:45-09:15 | 의편협과 XMLink의 역할 | 권오훈 (의편협 부회장) |
| 09:15-09:35 | Paradigm Shift in Journal Publishing: Electronic and/or Print Journal Publishing Workflow Integration | 이춘실 (숙명여대) |
| 09:35-09:45 | Discussion | 이춘실, 권오훈, 유병수, 황경국, 김장영 |
| 09:45-10:35 | Experiences and New Start | 전은석, 천영국 |
| 09:45-10:00 | 학술지의 발전 경험 1: 대한고혈압학회지 Clinical Hypertension | 정욱진 (대한고혈압학회지 편집장) |
| 10:00-10:15 | 학술지의 발전 경험 2: Korean Journal of Internal Medicine | 천영국 (대한내과학회지 편집장) |
| 10:15-10:25 | 대한심부전학회지 창간 의의 | 박성미 (대한심부전학회 편집이사) |
| 10:25-10:35 | Discussion | 이춘실, 권오훈, 이은소, 김명아, 신미승 |
| 11:00-12:10 | [Pre-symposium] Left Atrium: To Be or Not To Be |
오병희, 신준한 |
| 11:00-11:15 | What Would Be Life without Left Atrium? (Left Atrium: Anatomy, Function) | 이주희 (충북의대) |
| 11:15-11:30 | Effect of Arrhythmia (AF, APCs) on LA Hemodynamics | 유희태 (연세의대) |
| 11:30-11:45 | LA, The Size Matters! | 최홍미 (한림의대) |
| 11:45-12:00 | What You Do Not Know about Left Atrium or Others | 박성미 (고려의대) |
| 12:00-12:10 | Discussion | 김용진, 김학령, 장정윤, 조성우 |
| 12:10-12:40 | Satellite Symposium I <MSD> | 유규형 |
| 12:10-12:40 | The Benefit of Ezetimibe/Atorvastatin Combination in Coronary Patients | 최의영 (연세의대) |
| 13:30-14:30 | Biomarkers in HF | 유규형, 박대균 |
| 13:30-13:45 | What Is Biomarker in HF? | 유병수 (연세원주의대) |
| 13:45:14:00 | Biomarkers Update 2018: What Is Hot, What Is Not | 김다래 (성균관의대) |
| 14:00-14:15 | Biomarkers: Pitfalls and Practical Implications | 손정우 (연세원주의대) |
| 14:15-14:30 | Discussion | 김형섭, 윤현주, 원호연, 김현진 |
| 14:30-15:30 | [Joint Session with Surgery] When to Operate and When to Not |
박표원, 양동헌 |
| 14:30-14:45 | Low Flow Low Gradient AS: What Is Needed? | 심지영 (연세의대) |
| 14:45-15:00 | Myectomy for LVOT Obstruction; When? | 김욱성 (성균관의대) |
| 15:00-15:15 | Aortic Insufficiencies in Aortopathies | 박재형 (충남의대) |
| 15:15-15:30 | Discussion | 홍준화, 박성지, 이삭, 전웅 |
| 15:30-16:00 | Coffee Break | |
| 16:00-17:00 | [Debate Session] ICD Is Strongly Indicated for Non Ischemic Cardiomyopathy |
전은석, 김영훈 |
| 16:00-16:06 | Implantable Cardioverter Defibrillator (ICD) Therapy in HF Patients with Non Ischemic Heart Disease | 전은석 (성균관의대) |
| 16:06-16:23 | ICD Is Strongly Indicated for Non Ischemic Cardiomyopathy | 최종일 (고려의대) |
| 16:23-16:40 | ICD for Primary Prevention of Non Ischemic Cardiomyopathy | 이상언 (울산의대) |
| 16:40-16:45 | Rebuttal (Pro) | 이해영 (서울의대) |
| 16:45-16:50 | Rebuttal (Cons) | 박진주 (서울의대) |
| 16:50-17:00 | Discussion | 정보영, 정욱진, 최진오, 안민수 |
| 17:00-17:30 | [Eng] Plenary Lecture |
Kyu-Hyung Ryu (Korea) |
| 17:00-17:30 | Management of the Complex Multi-Morbid HF Patient | Andrew J. Stewart Coats (Monash Univ., Australia & Univ. of Warwick, UK)) |
| 17:30-18:00 | 총회 | |
| Room B | ||
|---|---|---|
| 12:10-12:40 | Satellite Symposium II <Boehringer Ingelheim> | 박대균 |
| 12:10-12:25 | CV Disease and CV Mortality in Patients with T2D | 신미승 (가천의대) |
| 12:25-12:40 | What Is the Clinical Relevance of CVOT Result for CVD Patient with T2D? | 김학령 (서울의대) |
| 13:30-14:30 | [Eng] HFpEF: New Concepts of Various Phenotypes |
Dong-Ju Choi (Korea), Jian Zhang (China) |
| 13:30-13:45 | AF and HFpEF | In-Cheol Kim (Keimyung Univ., Korea) |
| 13:45-14:00 | CAD and HFpEF | Seok-Jae Hwang (Gyeongsang National Univ., Korea) |
| 14:00-14:15 | DM, Obesity, LVH and HFpEF | Yuhui Zhang (Fuwai hospital, China) |
| 14:15-14:30 | Discussion | Yasuhiko Sakata, Sung Kee Ryu, Mi-Jeong Kim, Sung Hea Kim |
| 14:30-15:30 | [Eng] Translational Research for HF |
Myeong-Chan Cho (Korea), Jin-Oh Choi (Korea) |
| 14:30-14:45 | Novel Therapeutic Targets in HF | Giuseppe M.C. Rosano (St. George’s Hospitals NHS Trust Univ. of London, UK) |
| 14:45-15:00 | Immunosenescence in Cardiovascular Diseases | Jong-Chan Youn (Hallym Univ., Korea) |
| 15:00-15:15 | Pathophysiology of Diabetic Cardiomyopathy | Yasuhiko Sakata (Tohoku Univ., Japan) |
| 15:15-15:30 | Discussion | Sang-Hyun Ihm, Young Sup Byun, Hyun-Jai Cho, Jin Oh Na |
| 15:30-16:00 | Coffee Break | |
| 16:00-17:00 | [Debate Session] Revascularization Is Definitely Needed in Chronic Stable Ischemic HF c Reduced EF |
한규록, 김응주 |
| 16:00-16:06 | Introduction | 김응주 (고려의대) |
| 16:06-16:23 | Role of “Functional” Revascularization in Chronic HF | 이주명 (성균관의대) |
| 16:23-16:40 | Cons | 최성훈 (한림의대) |
| 16:40-16:45 | Rebuttal (Pro) | 김수중 (경희의대) |
| 16:45-16:50 | Rebuttal (Cons) | 윤창환 (서울의대) |
| 16:50-17:00 | Discussion | 최윤석 , 박성미, 임홍석, 정동섭 |
| Room C | ||
|---|---|---|
| 13:30-14:30 | [Joint Session with Cardiac Rehabilitation and Nursing] Cardiac Rehab and Nursing Issues in HF Patients |
한성우, 손연정 |
| 13:30-13:45 | Obstacle to Self Care in HF | 이경숙 (서울대) |
| 13:45-14:00 | Nutrition Support for HF Patients | 이주영 (서울아산병원) |
| 14:00-14:15 | Team Approach for Cardiac Rehabilitation for HF | 이병주 (부산의대) |
| 14:15-14:30 | Discussion | 성지동, 김응주, 김계훈 |
| 14:30-15:30 | [Eng] Promotion of HF Care in Asia-Pacific Countries |
I Nyoman Wiryawan (Indonesia), Eung Ju Kim (Korea) |
| 14:30-14:45 | How to Optimize Care of HF Patients | Eung Ju Kim (Korea Univ., Korea) |
| 14:45-15:00 | Promotion of HF Care in Indonesia | I Nyoman Wiryawan (Sanglah General Hospital, Indonesia) |
| 15:00-15:15 | Promotion of HF Care in China | Yuhui Zhang (Fuwai Hospital, China) |
| 15:15-15:30 | Discussion | Jian Zhang, Soon Jun Hong, Jae Hyuk Choi, Hyo-In Choi |
| 15:30-16:00 | Coffee Break | |
| 16:00-17:00 | Big Data and Machine Learning | 최동주, 유병수 |
| 16:00-16:15 | Machine Learning and Big Data | 김광수 (서울대학교병원) |
| 16:15-16:30 | New Approach of Analysis in Cardiovascular Epidemiology | 김현창 (연세의대) |
| 16:30-16:45 | CDM and Cardiovascular Research | 정세영 (서울의대) |
| 16:45-17:00 | Discussion | 박성지, 윤종찬, 김인철, 김미나, 오재원, 이주희 |
| Nov 17 (Sat), 2018 | ||
|---|---|---|
| Room A | ||
| 08:10-09:00 | Satellite Symposium II - Morning Review <Hanmi> | 채성철 |
| 08:10-08:35 | Evidence-Based Approach for Intensive BP Control | 윤종찬 (한림의대) |
| 08:35-09:00 | Towards Optimal Management of CV Risk in Hypertensive Patients with Dyslipidemia | 김성은 (한림의대) |
| 09:00-10:00 | [Kor/Eng] ICT and HF |
Dong-Ju Choi (Korea), Sungyoung Lee (Korea) |
| 09:00-09:15 | Intelligent Clinical Decision Support System for Cardiovascular Interventions | Taqdir Ali (Kyung Hee Univ., Korea) |
| 09:15-09:30 | Ubiquitous Health Profile: A Data Interoperability Framework for Cardiovascular Disease Management | Wajahat Ali Khan (Kyung Hee Univ., Korea) |
| 09:30-09:45 | Holographic Reality (HR) in Medicine | 김은수 (광운대) |
| 09:45-10:00 | Intelligent Medical Platform (IMP): A Novel A Dialogue-Based Platform for Healthcare Services | 이승룡 (경희대) |
| 10:00-11:00 | RV Failure and Hepatopathy | 채성철, 임세중 |
| 10:00-10:15 | RV Failure and Hepatopathy (Cardiac LC); Perspect of Cardiology | 최정현 (부산의대) |
| 10:15-10:30 | RV Failure and Hepatopathy (Cardiohepatic Syndrome); Perspect of Hepatology | 은혁수 (충남의대) |
| 10:30-10:45 | Hepatopathy in Fontan Circulation: What Is Different | 박수진 (부천세종병원) |
| 10:45-11:00 | Discussion | 정조원, 홍그루, 설상훈, 조상호 |
| 11:00-11:30 | Coffee Break | |
| 11:30-12:10 | Satellite Symposium IV <Novartis> | 전은석 |
| 11:30-11:50 | Hospitalized HF Patient Management with ARNI Recent Update Data | 박진주 (서울의대) |
| 11:50-12:10 | HF Management in Complicated Real-World Situation | 이상언 (울산의대) |
| 12:10-12:50 | Satellite Symposium VI <Bayer> | 김영권 |
| 12:10-12:30 | Managing NVAF Patients with HF: Where Are We Now? | 최진오 (성균관의대) |
| 12:30-12:50 | HF and Renal Impairment In NVAF: Why Dose It Matter? | 오재원 (연세의대) |
| 13:00-13:50 | Luncheon Symposium I <Servier> | 최동주 |
| 13:00-13:25 | Time Matters in the Management of HF Patients | Andrew J. Stewart Coats (Monash Univ., Australia & Univ. of Warwick, UK) |
| 13:25-13:50 | Ivabradine Case Sharing for HF Patients | 정욱진 (가천의대) |
| 13:50-15:00 | [Eng] [Joint Symposium with HFA of the ESC] Type 2 DM and HF |
Dong-Ju Choi (Korea), Andrew Coats (Australia) |
| 13:50-14:05 | T2DM and HF: What Is Known and What Is Unknown? | Andrew J. Stewart Coats (Monash Univ., Australia & Univ. of Warwick, UK) |
| 14:05-14:20 | T2DM and HF: Lessons from Korean Acute HF Registry | Jin Joo Park (Seoul Univ., Korea) |
| 14:20-14:35 | T2DM and HF: SLGT2 Inhibitor and HF | Giuseppe M.C. Rosano (St. George’s Hospitals NHS Trust Univ. of London, UK) |
| 14:35-14:50 | Diabetes and HFpEF: Insights from Asia | Yasuhiko Sakata (Tohoku Univ., Japan) |
| 14:50-15:00 | Discussion | Byung Su Yoo, Jae-Hyeong Park, Jong-Chan Youn, Darae Kim |
| 15:00-16:00 | Coffee Break and Moderated Poster | |
| 16:00-17:10 | Interesting Cases: Korea | 김기식, 김명아 |
| 16:00-16:15 | End-Stage Cardiomyopathy with Previous Malignancy | 최하늘 (가천의대) |
| 16:15-16:30 | Reversal of Pulmonary Hypertension with LVAD Therapy | 최효인 (울산의대) |
| 16:30-16:45 | The Tragedy of Two Family | 김미나 (고려의대) |
| 16:45-17:00 | Anthracycline-Induced Cardiomyopathy: Could It Be Reversible? | 정미향 (한림의대) |
| 17:00-17:10 | Discussion | 유규형, 전은석, 김재중, 강석민 |
| 17:10-17:20 | Closing Remark | |
| Room B | ||
|---|---|---|
| 08:10-09:00 | Satellite Symposium IV - Morning Review <Pfizer-BMS> | 강석민 |
| 08:10-08:35 | NOAC in Patients with Atrial Fibrillation Accompanied by HF | 양동헌 (경북의대) |
| 08:35-09:00 | Implementing Guidelines: Practical Considerations for Improving AF Patient Care with Apixaban | 최정현 (부산의대) |
| 09:00-10:00 | Recent Advance in Imaging Technologies for HF | 심완주, 최의영 |
| 09:00-09:12 | Recent Advance in Echocardiography for HF | 김은경 (성균관의대) |
| 09:12-09:24 | Recent Advance in Cardiac CT for HF | 임동진 (연세의대) |
| 09:24-09:36 | Recent Advance in Cardiac MRI for HF | 최의영 (연세의대) |
| 09:36-09:48 | Recent Advance in Nuclear Imaging for HF | 오주현 (가톨릭의대) |
| 09:48-10:00 | Discussion | 안효석, 조익성, 김형윤, 허란 |
| 10:00-11:00 | Interventional Management of HF | 주승재, 권현철 |
| 10:00-10:12 | Is IABP Really a Mechanical Placebo in a Patient with HF? | 김수중 (경희의대) |
| 10:12-10:24 | LV Unloading in a Patient Treated with VA ECMO: When and How? | 정재승 (고려의대) |
| 10:24-10:36 | What Is Optimal Strategy for Weaning of VA ECMO? | 장우진 (성균관의대) |
| 10:36-10:48 | Mechanical Support for Severe Refractory RV Failure | 조양현 (성균관의대) |
| 10:48-11:00 | Discussion | 한승환, 신미승, 양정훈, 김민석 |
| 11:00-11:30 | Coffee Break | |
| 13:00-13:50 | Luncheon Symposium II <Chong Kun Dang> | 김재중 |
| 13:00-13:25 | Carvedilol: Broad & Better Beta Blocker | 김경희 (메디플렉스 세종병원) |
| 13:25-13:50 | Unique Anti - Arrhythmic Effect of Carvedilol | 차명진 (서울의대) |
| 13:50-15:00 | Management of End-Stage HF | 김재중, 성기익 |
| 13:50-14:05 | When Is the Optimal Timing for Heart Transplantation Listing? | 김인철 (계명의대) |
| 14:05-14:20 | Indication of LVAD as BTT and DT | 최진오 (성균관의대) |
| 14:20-14:35 | Primary Graft Dysfunction after Heart Transplantation: Where Are We Standing? |
오재원 (연세의대) |
| 14:35-14:50 | Antibody-Mediated Rejection in Cardiac Transplantation: Emerging Knowledge in Diagnosis and Management | 김경희 (메디플렉스 세종병원) |
| 14:50-15:00 | Discussion | 윤영남, 정성호, 조양현, 이숙진 |
| 15:00-16:00 | Coffee Break and Moderated Poster | |
| 16:00-17:10 | [Joint Session with the Korean Association of Clinical Cardiology] HF for Primary Care Physician |
최동주, 김한수 |
| 16:00-16:15 | Diagnosis of HF for Primary Care Physician | 조재영 (전남의대) |
| 16:15-16:30 | Management of HF for Primary Care Physician | 장세용 (경북의대) |
| 16:30-16:45 | Referred HF Suspected Case Review | 박성지 (성균관의대) |
| 16:45-17:00 | What Primary Care Physicians Want for KSHF | 한경일 (서울내과) |
| 17:00-17:10 | Discussion | 두영철, 류재춘, 황경국, 박훈준 |
| Room C | ||
|---|---|---|
| 08:10-09:00 | [Eng]Early Career Research from the Asia-Pacific Region | Byung Su Yoo (Korea), Jian Zhang (China) |
| 09:00-10:00 | KSHF One Day Academy for HF: Session I (Diagnosis) | 김영권, 김동수 |
| 09:00-09:15 | Swan-Ganz Catheterization: Indication, Insertion, Interpretation | 양정훈 (성균관의대) |
| 09:15-09:30 | Pressure Volume Loop: The Key Physiology in HF | 심지영 (연세의대) |
| 09:30-09:45 | Cardiopulmonary Exercise Test | 김봉준 (고신의대) |
| 09:45-10:00 | Various Monitoring Parameters During ECMO | 김민석 (울산의대) |
| 10:00-11:00 | KSHF One Day Academy for HF: Session II (Medical Treatment) | 이상훈, 김동운 |
| 10:00-10:15 | Clinical Use of Beta-Blocker in HF with Reduced EF | 한성우 (한림의대) |
| 10:15-10:30 | ACEi/ARB | 서석민 (가톨릭의대) |
| 10:30-10:45 | Diuretics/Spironolactone - Case Based Learning | 정혜문 (경희의대) |
| 10:45-11:00 | Ivabradine/Sacubtril-Valsartan - Case Based Learning | 김경진 (이화의대) |
| 11:00-11:30 | Coffee Break | |
| 11:30-12:50 | 말기 심부전 환자의 연명치료 | 이윤성, 강석민 |
| 11:30-11:50 | Life-Sustaining Treatment in Korea, Now & How | 이윤성 (국가생명윤리정책원) |
| 11:50-12:10 | Problems with the End-of-Life Decision Act for Terminal Patients in Korea | 허대석 (서울의대) |
| 12:10-12:30 | 말기심부전환자의 연명치료, 제안 | 박상민 (한림의대) |
| 12:30-12:45 | Discussion | 박대균, 황경국, 조은주, 김현욱, 이수용 |
| 13:00-13:50 | KSHF One Day Academy for HF: Session III (Non-Medical Treatment) | 김영대, 신동구 |
| 13:00-13:15 | When Do We Apply Devices to HFrEF Patients? - Clinical Scenarios | 박승정 (성균관의대) |
| 13:15-13:35 | Cardiac Rehabilitation after Reimbursement - Pitfalls and Solutions | 김원석 (서울의대) |
| 13:35-13:50 | The Power of Education in HF Patients - Practical Approach | 손연정 (중앙대) |
| 13:50-15:00 | [Specialized Session for CRC] Basics of HF Clinical Trials |
홍석근, 최의영 |
| 13:50-14:10 | How Guideline Directed Medical Therapy in HF Was Established from Clinical Trials | 이선기 (한림의대) |
| 14:10-14:30 | Pitfalls and Practical Tips of HF Clinical Trials: CRC's Perspectives | 옥종선 (건국대) |
| 14:30-14:50 | Role of CRC in HF Clinical Trials: Physician's Perspectives | 조현재 (서울의대) |
| 14:50-15:00 | Discussion | 양동헌, 김용현, 최정현, 안정아 |
| 15:00-15:10 | Coffee Break | |
| 15:10-17:50 | 심혈관 검사 파트 | 안미숙, 안정아 |
| 15:10-16:00 | HF Management Program: The Nurse-Led HF Clinic | 이경은 (세브란스병원) |
| 16:00-16:50 | 심부전 환자의 시술과 간호(ICD, CRT(D) Implantation) | 유원우 (세브란스병원) |
| 16:50-17:30 | Cardiac Rehabilitation Program & Nursing for HF Patients | 김지수 (세브란스병원) |
| 17:30-17:50 | LVAD Implantation Patient Management: Concepts and Practices | 최남경 (삼성서울병원) |